Mechanisms of apoptosis induced by anticancer compounds in melanoma cells
1University of Illinois at Chicago, Department of Medicine, 840, S. Wood St., Room 1041, Chicago, IL 60612, USA. agartel@uic.edu
Abstract:
The sensitivity of cancer cells to apoptosis induced by anticancer drugs in vitro may be a predictor of their sensitivity to these drugs in vivo. In this review I summarize recent data describing anticancer drug-induced apoptosis in human melanoma cells. Proteasome inhibitors alone, or in combination with other drugs, efficiently induce apoptosis in melanoma cells. It has been shown that apoptosis induced by proteasome inhibitors is linked to suppression of transcription factor FoxM1 and upregulation of the proapoptotic Noxa protein. In addition, proteasome inhibitors stabilize the antiapoptotic Mcl-1 protein, and its suppression leads to more robust apoptosis in melanoma cells. Drugs targeting B-Raf (BAY 54-9085) or IKKb (BMS-345541) have been tested in melanoma cell lines, and it has been shown that the proapoptotic activity of both drugs depends on the inhibition of NF-kB in melanoma cells. A synthetic analog of dsRNA in complex with a polycation stimulated autophagy via induction of dsRNA helicase MDA-5 followed by apoptosis that was partially modulated by Noxa. These data may provide important information needed for designing more efficient combinations of anticancer drugs against melanoma.
Insights
Anticancer drugs induce apoptosis in melanoma cells by targeting key proteins and pathways. Understanding these mechanisms, like proteasome inhibition and NF-kB signaling, can improve melanoma treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- In vitro drug sensitivity of cancer cells can predict in vivo response.
- Human melanoma cells are a focus for studying anticancer drug-induced apoptosis.
Purpose of the Study:
- To review recent data on anticancer drug-induced apoptosis in human melanoma cells.
- To explore mechanisms of drug-induced apoptosis for improved melanoma treatment.
Main Methods:
- Review of existing literature on melanoma cell apoptosis.
- Analysis of drug mechanisms including proteasome inhibitors, B-Raf, and IKKb inhibitors.
- Investigation of signaling pathways like FoxM1, Noxa, Mcl-1, and NF-kB.
Main Results:
- Proteasome inhibitors induce apoptosis in melanoma cells by suppressing FoxM1 and upregulating Noxa.
- Proteasome inhibitors also affect Mcl-1 stability, influencing apoptosis.
- Targeting B-Raf or IKKb shows proapoptotic activity dependent on NF-kB inhibition.
- dsRNA analogs stimulate autophagy and apoptosis, modulated by Noxa.
Conclusions:
- Mechanisms of drug-induced apoptosis in melanoma involve specific protein and pathway modulation.
- Understanding these pathways is crucial for developing effective combination therapies for melanoma.
- Further research into these pathways can guide the design of novel anticancer drug strategies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

